Recent online commentaries have reignited a long-settled debate about vertebral augmentation (VA) for osteoporotic compression fractures—this time on social media rather than in scientific forums. In ...
The US Food and Drug Administration (FDA) has granted 510(k) clearance to Amber Implants’ VCFix Spinal System, intended for treating a wide array of vertebral compression fractures. The minimally ...
ArthroCare, a maker of minimally invasive surgical products, has received FDA clearance for its second-generation Parallax Contour-enhanced vertebral augmentation device, according to a news release.
MRI reduces vertebral compression fracture misdiagnoses before cementing MRI reduces the rate of misdiagnosis of acute lesions and hidden lesions before percutaneous cement augmentation procedures.
Amber Implants, an innovative medical technology company developing next-generation implants for spinal injuries, announced it has received clearance from the US Food and Drug Administration (FDA) for ...
A tailored exercise adherence intervention integrated into physiotherapy rehabilitation enhanced mobility outcomes in people with vertebral fragility fractures. At 12 months, participants who received ...
FDA clearance confirms robust safety and performance of VCFix® Spinal System, a breakthrough treatment for vertebral compression fractures US commercial pilot launch planned for early 2026, followed ...
FDA clearance confirms robust safety and performance of VCFix® Spinal System, a breakthrough treatment for vertebral compression fractures US commercial pilot launch planned for early 2026, followed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback